This topic contains a solution. Click here to go to the answer

Author Question: Thiabendazole is contraindicated in which patient? a. A 32-year-old woman with psoriasis b. A ... (Read 22 times)

elizabeth18

  • Hero Member
  • *****
  • Posts: 559
Thiabendazole is contraindicated in which patient?
 
  a. A 32-year-old woman with psoriasis
  b. A 17-year-old male with a femoral fracture
  c. A child under the age of 12 years
  d. A 35-year-old woman with cirrhosis

Question 2

A nurse provides education for a patient who has just started taking buspirone (BuSpar).
 
  The patient asks the nurse, When should I expect to see an effect from the medication? The nurse's best response would be based on the understanding that the effects of buspirone begin in most patients during which time frame? a. 3 days
  b. 24 to 48 hours
  c. 1 day
  d. 4 to 6 weeks



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

T4T

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

d

Answer to Question 2

D
Although an initial response to buspirone may occur as early as 1 week, it may take up to 4 to 6 weeks for peak results of the medication to occur.
One to 3 days is too short an interval to expect the effects of buspirone to develop.




T4T

  • Sr. Member
  • ****
  • Posts: 348

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library